Phenomenex Announces New Californian GC Column Facility
Phenomenex Inc. has announced the opening of a new manufacturing and development facility dedicated to the company’s gas chromatography columns.
Photo Credit: Phenonmenex Inc.
Phenomenex Inc. (Torrance, California, USA) has announced the opening of a new manufacturing and development facility dedicated to the company’s gas chromatography columns. The 15,000-square-foot facility located in Sacramento, California, USA, supports twice the production capacity, reportedly improving Phenomenex’s logistics and delivery speeds.
“Detailed and exhaustive planning went into creating an efficient production floor, using lean principles to maximize the use of space while minimizing the movement of people and materials,” said Emmet Welch, senior product development manager for Phenomenex.
“We have also included a centralized piping system that reduces the cost and movement of process gasses. With advanced, automated workflows, this new facility will be capable of supporting significant growth in Phenomenex GC manufacturing and new product development for many years,” continued Welch.
Commenting on the décor of the new facility, Phenomenex founder Fasha Mahjoor praised the “vibrant colours and pleasing architectural spaces.”
“Our people are the reason for our success, and it’s our goal and responsibility to give them an environment that inspires teamwork and camaraderie and promotes their health and wellbeing,” said Mahjoor.
For more information, please visit www.phenomenex.com
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.
Inside the Laboratory: The Richardson Group at the University of South Carolina
November 20th 2024In this edition of “Inside the Laboratory,” Susan Richardson of the University of South Carolina discusses her laboratory’s work with using electron ionization and chemical ionization with gas chromatography–mass spectrometry (GC–MS) to detect DBPs in complex environmental matrices, and how her work advances environmental analysis.
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Infographic: Be confidently audit ready, at any time and reduce failures in pharma QC testing
November 20th 2024Discover how you can simplify the audit preparation process with data integrity dashboards that provide transparency to key actions, and seamlessly track long-term trends and patterns, helping to prevent system suitability failures before they occur with waters_connect Data Intelligence software.
Critical Role of Oligonucleotides in Drug Development Highlighted at EAS Session
November 19th 2024A Monday session at the Eastern Analytical Symposium, sponsored by the Chinese American Chromatography Association, explored key challenges and solutions for achieving more sensitive oligonucleotide analysis.
